Product ID: SQMIG35G2238
Global Interventional Oncology Market Size, Share, Growth Analysis, By Therapy(Radiation Therapy, Ablation Devices), By Cancer Type(Liver Cancer, Kidney Cancer), By End-User(Hospitals, Ambulatory surgical centres), By Procedure([Embolization (TARE, TACE)), By Product Type(Embolization Devices, Ablation Devices) - Industry Forecast 2024-2031
Report ID:
SQMIG35G2238 |
Region:
Global |
Published Date: February, 2024
Pages:
242
|
Tables:
147 |
Figures:
78
Global Interventional Oncology Market Competitive Landscape
The market's key players are undertaking various strategic initiatives such as the signing of a collaborations, new partnership agreement, mergers and acquisitions, geographic coverage, with the goal of strengthening their product portfolio and manufacturing capacities, thereby providing a competitive advantage. In 2021, Boston Scientific (US) led the worldwide interventional oncology market. To improve its market presence and product offerings, the corporation primarily relies on growth tactics such as acquisitions and expansions. The acquisition of BTG by the firm will help it increase its product portfolio in chemoembolization, radioembolization, and ablation treatments. Boston Scientific works hard to get regulatory and reimbursement approvals. As part of its long-term growth plan, the firm invests in both fast-growing and new areas in order to improve its position in the global healthcare sector.
Interventional Oncology Market Top Player's Company Profiles
- Medtronic (Ireland)
- Teleflex (US)
- Boston Scientific Corporation
- BTG International Ltd. (acquired by Boston Scientific)
- Cook Medical Inc.
- AngioDynamics Inc.
- Terumo Corporation
- Merit Medical Systems Inc.
- Johnson & Johnson Services Inc.
- MedWaves, Inc.
- Healthtronics Inc.
- Trod Medical
- InSightec Ltd.
- Sirtex Medical Limited
- Sanarus Technologies, LLC
- C.R. Bard, Inc. (acquired by Becton, Dickinson and Company)
- Guerbet Group
- Varian Medical Systems, Inc.
- Nanobiotix SA
- OncoTherapy Science, Inc.
Interventional Oncology Market Recent Development
- In September 2022, Philips announces significant development milestones for the world's first spectral detector Angio CT system. Leiden University Medical Centre has joined a global network of partners in the development of the Philips Spectral Angio CT suite and its application in clinical research, bringing spectral CT imaging technology into an integrated hybrid Angio CT suite with the goal of innovating a variety of treatment procedures.
- In September 2022, Merit Medical Systems, Inc. a global manufacturer and marketer of healthcare equipment, has announced the commercial launch of the Prelude Roadster Guide Sheath in the United States. The Merit Vascular-Peripheral Access portfolio now includes the Prelude Roadster, in addition to introducers and other devices such as access kits, vascular dilators, and accessories.
- In September 2022, Aster Hospitals Bengaluru, a subsidiary of Aster DM Healthcare, has established the Aster International Institute of Oncology (AIIO). This newly established institute will serve as a centre of excellence for the treatment of all malignancies under one roof.
Global Interventional Oncology Market Report Snapshots
Want to customize this report?
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATION
USA (+1) 351-333-4748
